Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Deere & Co. | DE | Sep 4, 2024 | 391.95 | +1.62 |
DEFA Equity Income Wisdomtree | DTH | Sep 4, 2024 | 40.58 | +0.18 |
DEFA Wisdomtree | DWM | Sep 4, 2024 | 56.54 | -0.11 |
Definitive Healthcare | DH | Sep 4, 2024 | 4.50 | -2.60 |
Delcath Systems | DCTH | Sep 4, 2024 | 10.86 | +2.84 |
Delek Logistics Partners LP Unit | DKL | Sep 4, 2024 | 42.17 | -0.68 |
Delek US | DK | Sep 4, 2024 | 20.34 | -2.59 |
Dell Technologies C | DELL | Sep 4, 2024 | 109.06 | -1.54 |
Delta Air Lines | DAL | Sep 4, 2024 | 42.37 | 0.00 |
Deluxe | DLX | Sep 4, 2024 | 19.71 | -0.05 |
Denali Capital Acquisition A | DECA | Sep 4, 2024 | 11.53 | +0.44 |
Denali Capital Acquisition Unit | DECAU | Sep 4, 2024 | 11.53 | 0.00 |
Denali Therapeutics | DNLI | Sep 4, 2024 | 25.16 | +0.16 |
Denison Mines | DNN | Sep 4, 2024 | 1.53 | 0.00 |
Dennys | DENN | Sep 4, 2024 | 6.20 | +0.81 |
DENTSPLY SIRONA | XRAY | Sep 4, 2024 | 25.55 | +2.20 |
Dermata Therapeutics | DRMA | Sep 4, 2024 | 1.51 | -5.63 |
DermTech | DMTK | Sep 4, 2024 | 0.09 | 0.00 |
Descartes Systems Group | DSGX | Sep 4, 2024 | 98.75 | -0.89 |
Design Therapeutics | DSGN | Sep 4, 2024 | 4.81 | +1.69 |
Designer Brands A | DBI | Sep 4, 2024 | 6.06 | -1.14 |
Desktop Metal A | DM | Sep 4, 2024 | 4.27 | 0.00 |
Despegar.com | DESP | Sep 4, 2024 | 12.24 | +3.99 |
Destiny Tech100 | DXYZ | Sep 4, 2024 | 11.51 | -0.09 |
Destra Multialternative Fund | DMA | Sep 4, 2024 | 8.35 | 0.00 |
Deswell Industries | DSWL | Sep 4, 2024 | 2.30 | +0.88 |
Deutsche Bank | DB | Sep 4, 2024 | 15.97 | +0.31 |
Dev Mkts Ex-US Alphadex First Trust | FDT | Sep 4, 2024 | 55.97 | -0.57 |
Dev Mkts Ex-US SC Alphadex First Trust | FDTS | Sep 4, 2024 | 41.99 | +0.15 |
Devon Energy | DVN | Sep 4, 2024 | 42.24 | -1.81 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.